SCHEMBL16419784

SCHEMBL16419784

NCCCOc1cc(-c2ccc3ccc(-c4cc(OCCCN)c(OCCCN)c(OCCCN)c4)cc3c2)cc(OCCCN)c1OCCCN

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1B P28222 2/20 0.40
▸ MAOA P21397 1/20 0.38
▸ MELK Q14680 1/20 0.34
▸ CHEK1 O14757 1/20 0.34
▸ FFAR4 Q5NUL3 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ MKNK1 Q9BUB5 1/20 0.32
▸ MKNK2 Q9HBH9 1/20 0.32
▸ ESR1 P03372 1/20 0.32
▸ ESR2 Q92731 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16419754 0.93 BCHE (0.40) HTR1BMAOAKDM4EMEN1ALDH1A1
SCHEMBL16419772 0.79 CSF3R (0.42) HTR1BMAOAKDM4EMAPK1MKNK2
SCHEMBL15036875 0.78 HTR1B (0.45) HTR1BMAOAMELKKDM4EHPGD
SCHEMBL16419743 0.73 CHRNB2 (0.43) KDM4EPOLBMAPTHPGDHSD17B10
SCHEMBL15805960 0.73 PIM1 (0.39) HTR1BMELKCHEK1MAPK1
SCHEMBL16169700 0.73 PIM1 (0.39) HTR1BMELKCHEK1KDM4EMEN1
SCHEMBL4355741 0.72 HTR1B (0.40) HTR1BMAOAKDM4EMEN1ALDH1A1
SCHEMBL16419762 0.72 CYP1A2 (0.45) HTR1BMELKMAPK1SMN1; SMN2
SCHEMBL15036796 0.70 CA1 (0.46) MEN1KMT2A
SCHEMBL16169699 0.69 PIM1 (0.40) HTR1BKDM4EMAPTMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9469616-B2 Cyclic compounds and methods of making and using the same CELLCEUTIX CORPORATION (US) 2016-10-18 — — US disclosed
US-20150031738-A1 CYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME UNIVERSITY OF MASSACHUSETTS (US) 2015-01-29 — — US disclosed
US-20150031738-A1 CYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME UNIVERSITY OF MASSACHUSETTS (US) 2015-01-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150031738-A1 CYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME MUC1, TLR3, ALG1 HTR1B 4113/4885MAOA 3631/4885MELK 1047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback